Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

Min, Myintzu; Spelman, Tim; Lugaresi, Alessandra; BOZ, CAVİT; Spitaleri, Daniele; Pucci, Eugenio; Grand'Maison, Francois; Granella, Franco; Izquierdo, Guillermo; Butzkueven, Helmut; Luis Sanchez-Menoyo, Jose; Barnett, Michael; Girard, Marc; Trojano, Maria; Grammond, Pierre; Duquette, Pierre; Sola, Patrizia; Alroughani, Raed; Hupperts, Raymond; Vucic, Steve; Kalincik, Tomas; Van pesch, Vincent; Lechner-Scott, Jeannette

doi:10.1177/1352458518798147

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

Min M., Spelman T., Lugaresi A., BOZ C., Spitaleri D. L. A., Pucci E., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.24, sa.12, ss.1569-1577, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 12
Basım Tarihi: 2018
Doi Numarası: 10.1177/1352458518798147
Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1569-1577
Anahtar Kelimeler: Disease-modifying therapy, magnetic resonance imaging, subclinical lesions, MAGNIMS CONSENSUS GUIDELINES, MS, RECOMMENDATIONS, PERFORMANCE, IMPAIRMENT, DISABILITY, DIAGNOSIS
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: The current best practice suggests yearly magnetic resonance imaging (MRI) to monitor treatment response in multiple sclerosis (MS) patients.